A detailed history of Global Retirement Partners, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Global Retirement Partners, LLC holds 139 shares of NBIX stock, worth $17,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares
139
Previous 152 8.55%
Holding current value
$17,233
Previous $20,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$114.58 - $153.15 $1,489 - $1,990
-13 Reduced 8.55%
139 $16,000
Q2 2024

Jul 23, 2024

SELL
$130.86 - $143.19 $5,234 - $5,727
-40 Reduced 20.83%
152 $20,000
Q1 2024

Apr 23, 2024

BUY
$130.4 - $143.74 $1,043 - $1,149
8 Added 4.35%
192 $26,000
Q4 2023

Jan 18, 2024

SELL
$106.07 - $132.76 $9,228 - $11,550
-87 Reduced 32.1%
184 $24,000
Q3 2023

Oct 13, 2023

BUY
$94.02 - $117.1 $1,222 - $1,522
13 Added 5.04%
271 $30,000
Q2 2023

Jul 20, 2023

BUY
$89.53 - $104.87 $13,160 - $15,415
147 Added 132.43%
258 $24,000
Q1 2023

May 05, 2023

BUY
$94.11 - $123.02 $470 - $615
5 Added 4.72%
111 $11,000
Q4 2022

Feb 13, 2023

SELL
$106.72 - $127.06 $533 - $635
-5 Reduced 4.5%
106 $12,000
Q4 2022

Feb 13, 2023

SELL
$106.72 - $127.06 $533 - $635
-5 Reduced 4.5%
106 $12,000
Q3 2022

Nov 03, 2022

BUY
$92.03 - $107.81 $9,479 - $11,104
103 Added 1287.5%
111 $13,000
Q1 2022

Jul 14, 2022

BUY
$72.45 - $94.81 $579 - $758
8 New
8 $1,000
Q1 2021

Apr 14, 2021

SELL
$87.57 - $119.4 $1,663 - $2,268
-19 Closed
0 $0
Q4 2020

Jan 13, 2021

BUY
$86.91 - $108.33 $1,651 - $2,058
19 New
19 $2,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.